Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706549PMC
http://dx.doi.org/10.1016/j.jclinepi.2022.08.017DOI Listing

Publication Analysis

Top Keywords

understanding deferred
4
deferred consent
4
consent patient
4
patient characteristics
4
characteristics outcomes
4
outcomes exploratory
4
exploratory analysis
4
analysis clinical
4
clinical trial
4
trial prone
4

Similar Publications

Article Synopsis
  • Social rejection is linked to negative health effects, but its impact on decision-making is less understood, especially in the context of social media.
  • The study investigated how experiences of acceptance and rejection influenced participants' choices, revealing that after rejection, individuals were more inclined to make their own decisions unless they felt particularly negative afterward.
  • Additionally, feelings of negativity affected participants' willingness to engage socially in the future, and individual differences like social anxiety played a role in how they made choices.
View Article and Find Full Text PDF

Background: Low-income pregnant patients are at high risk of postpartum depression (PPD). Mothers and Babies (MB) is a cognitive behavioral therapy-based program that prevents up to 50% of de novo PPD when provided in person to low-income Spanish- and English-speaking people who are pregnant without depression. MB is limited by the need for trained personnel to support it.

View Article and Find Full Text PDF

This review aims to address the impact of digital health interventions (DHIs) on chronic pain management, specifically, mHealth, eHealth, wearable devices, virtual reality (VR), and artificial intelligence. The following study identifies and assesses DHIs' efficacy in specific chronic pain conditions and then extrapolates improved outcomes and patient groups that benefit from their use. Using a systematic methodology, this review synthesizes findings that could improve knowledge for patients and practitioners in chronic pain management while also addressing gaps in understanding the impact of DHIs.

View Article and Find Full Text PDF

Parent Perspectives on Nirsevimab for Their Newborn.

Pediatrics

December 2024

Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.

Article Synopsis
  • In 2023, nirsevimab was approved in the U.S. as a monoclonal antibody to prevent bronchiolitis in newborns caused by RSV, prompting a study on parental responses to this recommendation.
  • A study involving 28 parents revealed that 38% planned to administer nirsevimab, 25% opted out, and the remaining were uncertain, highlighting significant knowledge gaps about RSV and the treatment.
  • Key concerns for parents included trust in pediatricians, fear of side effects, and misinformation likening nirsevimab to the COVID-19 vaccine, suggesting the need for improved awareness and communication among healthcare providers and parents.
View Article and Find Full Text PDF

Gonadal Tumors in Individuals with Turner Syndrome and Y-Chromosome Mosaicism: A Retrospective Multisite Study.

J Pediatr Adolesc Gynecol

November 2024

Pediatric and Adolescent Gynecology, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland.

Study Objective: To evaluate the prevalence of germ cell tumors and the clinical monitoring practices for those who deferred prophylactic gonadectomy in a large North American cohort of individuals with Turner syndrome with Y-chromosome mosaicism (TS+Y).

Method: A query of the medical records at multiple North American children's hospitals was done using ICD codes related to Turner Syndrome. A retrospective chart review was conducted on those patients between ages 0 to 30 years with Y-mosaicism.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!